For best experience please turn on javascript and use a modern browser!
Bekijk de site in het Nederlands

The advent of combination antiretroviral therapy (cART) has revolutionised the prognosis for people with HIV. Ensuring sustained viral suppression and optimal immune recovery during cART are key requirements underlying the success of treatment. Nevertheless, in a substantial number of patients, viraemia (viral sepsis) has been observed. Shuangjie Zhang focuses on the challenges accompanying this phenomenon.

Event details of Viraemia in HIV-1 infection
Date 10 February 2015
Time 12:00 -13:00
Location Agnietenkapel

S. Zhang, The Clinical Impact of Immunodeficiency and Viraemia in the Era of Combined Antiretroviral Therapy for HIV-1 Infection.


Prof. P. Reiss


Dr F. de Wolf


Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam


This event is open to the public.